Ventas, Inc.

Ventas Announces Third Quarter 2026 Earnings Release Date and Conference Call

Ventas, Inc. (NYSE: VTR) will issue its third quarter 2026 earnings release after market close on Tuesday, October 27, 2026. A conference call to discuss results will be held Wednesday, October 28, 2026 at 10:00 a.m. Eastern Time, with dial-in and webcast access via the company's investor relations site. This is a routine scheduling notice containing no financial results or guidance.

•0mo ago

VTR: 8-K · leadership change

Ventas, Inc. approved the appointment of Laurida Sayed as its Senior Vice President, Chief Accounting Officer and Controller, effective on or around October 5, 2026, according to an 8-K filed September 15, 2026. Ms. Sayed, 44, joins from Cushman & Wakefield Ltd., where she has been Chief Accounting Officer since May 2024 after prior senior controller roles at the firm. Once she starts, CFO Robert F. Probst will stop covering the Chief Accounting Officer role on an interim basis but remains Ventas' Chief Financial Officer. Her offer letter provides a $500,000 annual base salary, a target annual bonus of 60% of base salary, a $150,000 one-time cash sign-on bonus, and a $350,000 restricted stock unit grant vesting ratably over three years. The filing notes she has no related-party transactions, family ties to directors or officers, or arrangements underlying her selection.

SEC 8-K•1mo ago

Ventas Declares Quarterly Dividend of $0.52 Per Common Share

Ventas' board declared a quarterly cash dividend of $0.52 per common share, payable October 15, 2026. Stockholders of record as of the close of business on September 30, 2026 will receive the payment. Ventas is an S&P 500 healthcare REIT with roughly 1,450 properties across North America and the UK, anchored by more than 900 senior housing communities.

•1mo ago

Ventas Releases 2025-2026 Corporate Sustainability Report

Ventas released its 2025-2026 Corporate Sustainability Report, outlining initiatives designed to support its business strategy and strengthen asset performance within the longevity economy. The report is structured around three pillars—Sustainable Business, Exceptional Employees, and High Standards—and aligns with Global Reporting Initiative (GRI) and IFRS S2 disclosure standards. Ventas owns approximately 1,450 properties, including more than 900 senior housing communities, and utilizes its operational expertise and data-driven insights to drive performance.

•2mo ago

Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call

Ventas announced that it will release its second quarter 2026 earnings after the market closes on Wednesday, July 29, 2026. A conference call to discuss the results is scheduled for the following day, Thursday, July 30, 2026, at 10:00 a.m. Eastern Time. The call will be accessible via dial-in and webcast, with a replay available for 30 days.

•3mo ago

Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research

Ventas appointed Andrew L. Wattula as Executive Vice President of Outpatient Medical & Research and CEO of Lillibridge Healthcare Services, effective August 2026. Wattula succeeds Peter J. Bulgarelli, who retired in May 2026, and joins from Hudson Pacific Properties where he served as COO. He will report to Chairman and CEO Debra A. Cafaro, focusing on driving operational excellence in the company's outpatient medical and research portfolio.

•4mo ago

VTR: 8-K · leadership change

Ventas, Inc. announced that Carey S. Roberts will resign as Executive Vice President, General Counsel, Ethics & Compliance Officer, and Corporate Secretary effective June 26, 2026. Roberts intends to join Blackstone, Inc. as Senior Managing Director and General Counsel for its Real Estate division. Kevin M. Bohl, currently Senior Vice President and Deputy General Counsel, will assume the responsibilities of General Counsel, Ethics & Compliance Officer, and Corporate Secretary on an interim basis. The filing was signed by CFO Robert F. Probst, indicating no immediate replacement for the CFO role.

SEC 8-K•4mo ago

Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement

Ventas CEO Debra Cafaro will receive the Cyrus McCormick Making History Award for Historic Corporate Achievement at the Chicago History Museum. The award recognizes her leadership in growing Ventas from a $200 million market cap in 1999 to over $40 billion today, establishing it as a leading enterprise in the longevity economy. Ventas now owns over 1,400 properties, including 900 senior housing communities serving nearly 100,000 residents, and holds an enterprise value of approximately $57 billion.

•4mo ago

Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit’s REITweek 2026 Investor Conference

Ventas issued a standard business update and confirmed management will participate in investor meetings at Nareit’s REITweek 2026 Investor Conference. The company highlighted its portfolio of more than 1,400 properties across North America and the UK, including approximately 900 senior housing communities. No new financial results or guidance were provided in this release; it serves primarily as a reminder of upcoming investor engagement.

•4mo ago

VTR: 8-K · offering registration

Ventas, Inc. filed an 8-K reporting the amendment of its At-The-Market (ATM) equity sales agreement to increase the aggregate gross sales price capacity from $2.5 billion to $3.0 billion. This amendment, executed with a syndicate of major investment banks including BofA Securities and J.P. Morgan, provides the company with enhanced flexibility to raise capital through opportunistic share issuances, though no shares were sold in connection with this filing. The filing also disclosed the departure of Peter J. Bulgarelli, Executive Vice President of Outpatient Medical & Research, who retired on May 1, 2026. Bulgarelli will receive a prorated 2026 bonus contingent on a standard release of claims and compliance with restrictive covenants, marking a routine leadership transition within the company's outpatient division. Additionally, the 8-K reported the results of the company’s 2026 Annual Meeting of Stockholders held on May 13, 2026. Shareholders approved the election of all 12 director nominees, ratified the selection of KPMG LLP as independent auditor, and approved the advisory compensation of Named Executive Officers, with 93.5% of outstanding shares represented at the meeting.

SEC 8-K•5mo ago